Falcon Edge Capital 13F holdings, Q1 2015
Holdings as of March 31, 2015 · filings on SEC EDGAR · latest filing →
Falcon Edge Capital disclosed 19 US equity positions worth $2.0bn in its Q1 2015 13F filing. The largest position was LNG at 13.0% of the reported book, followed by BABA and ACTAVIS PLC. Against the Q4 2014 filing, it opened 5 new positions, added to 3 and reduced 3 among the top 19 holdings.
What did Falcon Edge Capital own in Q1 2015? Top 19 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2014 |
|---|---|---|---|---|---|---|---|
| 1 | LNG CHENIERE ENERGY INC | Energy | 13.0% | $257.6m | 3,327,914 | 0% | held |
| 2 | BABA ALIBABA GROUP HLDG LTD | Consumer Cyclical | 11.2% | $222.5m | 2,673,000 | 181% | added |
| 3 | ACTAVIS PLC | 9.4% | $187.1m | 628,542 | 46% | added | |
| 4 | S9Q SPIRIT AEROSYSTEMS HLDGS INC | 8.7% | $173.0m | 3,314,331 | -31% | reduced | |
| 5 | LIBERTY INTERACTIVE CORP | 7.4% | $146.8m | 3,495,000 | – | new | |
| 6 | ALLE ALLEGION PUB LTD CO | Industrials | 5.8% | $115.5m | 1,888,344 | 0% | held |
| 7 | BRK/A BERKSHIRE HATHAWAY INC DEL | 5.3% | $104.4m | 480 | 0% | held | |
| 8 | CDK CDK GLOBAL INC | 4.6% | $92.4m | 1,975,000 | -5% | reduced | |
| 9 | VALE VALE S A | 4.6% | $92.0m | 18,970,000 | 54% | added | |
| 10 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 4.6% | $91.0m | 871,713 | -36% | reduced |
| 11 | PRICELINE GRP INC | 4.0% | $79.3m | 68,100 | 0% | held | |
| 12 | INTERCEPT PHARMACEUTICALS IN | 3.9% | $77.6m | 275,000 | – | new | |
| 13 | DAL DELTA AIR LINES INC DEL | Industrials | 3.9% | $77.2m | 1,716,000 | 0% | held |
| 14 | PANDORA MEDIA INC | 3.8% | $75.7m | 4,670,900 | – | new | |
| 15 | MASONITE INTL CORP NEW | 3.7% | $74.1m | 1,102,000 | 0% | held | |
| 16 | JUMEI INTL HLDG LTD | 3.1% | $62.5m | 3,953,000 | – | new | |
| 17 | TEKMIRA PHARMACEUTICALS CORP | 2.0% | $38.8m | 2,221,000 | – | new | |
| 18 | OI S.A. | 0.7% | $14.2m | 9,245,523 | 0% | held | |
| 19 | OI S.A. | 0.3% | $5.9m | 3,622,022 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.